Loss of Dicer expression is associated with breast cancer progression and recurrence.
about
Roles for miRNAs in endocrine resistance in breast cancerMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerMicroRNA biogenesis pathways in cancerPrognostic significance of deregulated dicer expression in breast cancerThe expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer.MicroRNA Machinery Genes as Novel Biomarkers for CancerAltered expression of the miRNA processing endoribonuclease Dicer has prognostic significance in human cancers.Performance comparison of digital microRNA profiling technologies applied on human breast cancer cell lines.Reduction of protein kinase C α (PKC-α) promote apoptosis via down-regulation of Dicer in bladder cancerExpression of dicer and its related miRNAs in the progression of prostate cancerUp-regulation of matrix metalloproteinases in a mouse model of chemically induced colitis-associated cancer: the role of microRNAs.High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer.Low DICER1 expression is associated with attenuated neutrophil differentiation and autophagy of NB4 APL cells.Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell LinesHigh copy number variation of cancer-related microRNA genes and frequent amplification of DICER1 and DROSHA in lung cancer.MicroRNA Biogenesis and Hedgehog-Patched Signaling Cooperate to Regulate an Important Developmental Transition in Granule Cell Development.Pathways to breast cancer recurrence.Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer.Noncoding RNAs in breast cancer.Down-Regulation of Ca2+-Activated K⁺ Channel KCa1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists.A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis.The modulation of Dicer regulates tumor immunogenicity in melanoma.Dysregulation of microRNA biogenesis machinery in cancer.DICER governs characteristics of glioma stem cells and the resulting tumors in xenograft mouse models of glioblastomaRole of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis.MicroRNAs and anticancer drugs.Roles of microRNA-140 in stem cell-associated early stage breast cancer.MicroRNA-140 mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.miRNAs: mediators of ErbB family targeted therapy resistance.Impaired DICER1 function promotes stemness and metastasis in colon cancer.HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis.MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs.Role of Dicer1 in thyroid cell proliferation and differentiation.Complexity in regulation of microRNA machinery components in invasive breast carcinoma.Dysregulated expression of Dicer in invasive ductal breast carcinoma.Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.Argonaute 2 Expression Correlates with a Luminal B Breast Cancer Subtype and Induces Estrogen Receptor Alpha Isoform Variation.
P2860
Q26783076-C507E331-6335-4345-AAE2-25D17B66E7E4Q26801108-E9C2D010-96AD-4B9B-B917-2CD2E42AB7FBQ27013841-56FAD37D-D649-4B71-99F9-D6258C1961E2Q28393448-5E50D3F5-63BA-4066-AEBB-179D3F3B542AQ33613310-788A0A08-9EE3-4A53-B18B-7015A85EBBE7Q33657886-303082E2-ADDF-41E5-B89D-5EF5BADC3BE4Q34319010-5818B6DB-B8CF-49E4-BF7C-673DA7523EC5Q35014565-B40C3949-6AB5-4AFA-90D5-C3BF4F2A1C92Q35571946-14E9134D-4779-4134-B9A3-6CCF3168DB4CQ35576785-9A8D7168-9EC1-4272-88A6-075B44917B8CQ35741699-7AC9E28C-8AD5-46CF-9DD0-392E24829E22Q35815004-0C82F005-68C7-484D-876C-04100E648196Q35970498-7FC9F5C6-112A-4D29-A95D-02B7ED4C02A0Q36118327-5889616C-B89D-49BF-9F9D-732EDE71A75FQ36414198-B978933B-C4A5-4A54-A282-85185FB33B08Q36677081-85118F9A-E776-449B-8EDF-FC412EB21B6EQ36702139-E83BB299-2014-4F5A-AB5D-A4ACE0E34050Q36898429-7CDBDBFD-5371-445D-A354-E3D654C185C5Q36935047-5F3F7C69-62FB-4BED-99B3-E3D1B67B4456Q37534790-EB50662C-A648-41CC-8A0C-B78577564CF5Q37565007-A61EA37E-2F33-4433-8782-67A36C60CCB5Q37565233-E65C50CC-E563-41C0-BC4C-CAB0D7C50B61Q37580463-67E85D55-EB02-4C79-9978-239F982AAC42Q37636641-17AAD6A3-32DA-4C8C-96CF-A43226E7B09AQ37687278-126F0B46-61F2-4AFB-904B-EBEB6DAB3A1AQ38184857-2A06EFD4-4640-4741-A3CE-639B0ADA0309Q38271600-932BEFF6-95F4-4E63-B4A9-AB2FCDD0CB47Q38720709-9EA6AB6F-CBC0-4B85-9171-F7D0ED4E25A9Q38766652-2A8B20D2-F594-48BD-9363-5072F107DB62Q38881549-51BE1CCD-B5A9-4C34-B401-74C537A16B7BQ41933258-8FEBC408-D664-484E-8CD5-C1B3C4060E57Q47282038-B3B3F5D0-5A85-492B-AC3B-A5413875968CQ47726182-A3B64A96-21DB-4F67-B316-59CCE8F1B5E9Q47768823-0D216A9C-210D-4AB0-AEA4-51360C98F6E4Q53293967-41B059F6-F158-4643-ABC5-79A5A4740223Q53466891-82DFC200-BD68-4A17-8167-320240E4CE2CQ54328984-31E55940-8CFF-4C38-8F9F-CE1A754A82DAQ55137520-5E4CE5C9-D546-4F6E-B6A5-C376C5E7075B
P2860
Loss of Dicer expression is associated with breast cancer progression and recurrence.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Loss of Dicer expression is associated with breast cancer progression and recurrence.
@en
Loss of Dicer expression is associated with breast cancer progression and recurrence.
@nl
type
label
Loss of Dicer expression is associated with breast cancer progression and recurrence.
@en
Loss of Dicer expression is associated with breast cancer progression and recurrence.
@nl
prefLabel
Loss of Dicer expression is associated with breast cancer progression and recurrence.
@en
Loss of Dicer expression is associated with breast cancer progression and recurrence.
@nl
P2093
P50
P1476
Loss of Dicer expression is associated with breast cancer progression and recurrence.
@en
P2093
Christopher C Nolan
Douglas R Macmillan
Sarkawt M Khoshnaw
Tarek M Abdel-Fatah
Zsolt Hodi
P2888
P304
P356
10.1007/S10549-012-2169-3
P407
P577
2012-07-21T00:00:00Z